• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Drug Resist . The Value of Common Laboratory Markers in Predicting the Severity of COVID-19 Patients

tetano

Editor, Senior Moderator
Infect Drug Resist


. 2024 Nov 13:17:5037-5047.
doi: 10.2147/IDR.S478798. eCollection 2024. The Value of Common Laboratory Markers in Predicting the Severity of COVID-19 Patients

Lian Chen[SUP] #[/SUP][SUP] 1 [/SUP], Yu-Huan Jiang[SUP] #[/SUP][SUP] 2 [/SUP], Mei-Yong Li[SUP] 3 [/SUP], Bo Huang[SUP] 3 [/SUP], Lei Yuan[SUP] 2 [/SUP], Jin-Hua Wan[SUP] 2 [/SUP], Ting-Yu Qin[SUP] 2 [/SUP], Ting-Ting Zeng[SUP] 2 [/SUP], Qing-Gen Chen[SUP] 2 [/SUP]



Affiliations
Abstract

Purpose: The aim of the present study was to identify more effective laboratory markers to assess the severity of corona virus disease 2019 and predict the progression of the disease by collecting more laboratory markers and variables.
Patients and methods: In this study, most risk factors, including epidemiological characteristics, blood cell counts, cytokines, and infection markers, were collected from 126 patients with COVID-19 to assess their predictive value.
Results: The area under curve (AUC) of Albumin (Alb) to fibrinogen (Fib) ratio (AFR) (0.791), Lactate dehydrogenase (LDH) (0.792), myoglobin (MYO) (0.795), C-reactive protein (CRP) (0.801) and lymphocyte count (0.859) were higher than other markers to distinguish severe from non-severe patients in receiver operating characteristic (ROC) analysis. In the univariate logistic regression analysis, thirty-six out of 46 risk factors, including 34 laboratory markers, were significantly associated with increased odds of severe patients. Multivariate logistic regression analysis showed that the CD19+ lymphocyte count, MYO, LDH, and AFR were associated with increased odds of severe disease. Moreover, Lymphocyte count and AFR levels increased, LDH and CRP levels decreased during hospitalization in recovered severe patients, whereas severe lymphocytopenia and continuously increasing LDH levels were observed in deteriorated patients. AFR level increased and CRP level decreased before the disease worsened in the deteriorated patients; however, when the patients deteriorated, AFR decreased and CRP increased significantly.
Conclusion: CD19+ lymphocyte count, MYO, LDH, and AFR are independent biomarkers for early identification of severe COVID-19. Lymphocyte count, AFR, LDH, and CRP levels were helpful in predicting the clinical progression of the disease.\.

Keywords: Albumin to fibrinogen ratio; C-reactive protein; Coronavirus Disease 2019; Inflammation; Lymphocyte.

 
Back
Top Bottom